115 related articles for article (PubMed ID: 37750446)
1. Xerostomia: An easily ignored symptom induced by induction chemotherapy in patients with nasopharyngeal carcinoma.
Zhou P; Zhou R; Yu YF; Rao MY; Wu SG
Head Neck; 2023 Dec; 45(12):3024-3032. PubMed ID: 37750446
[TBL] [Abstract][Full Text] [Related]
2. Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
Zhao DW; Fan WJ; Fang XM; Luo YR; Wei J; Chen NX; Zhang XX; Liu G; Li JF; Zang X; Li M; Meng L; Ma L
Radiother Oncol; 2022 Jul; 172():91-98. PubMed ID: 35584742
[TBL] [Abstract][Full Text] [Related]
3. Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
Xiang L; Rong JF; Xin-Chen ; Li XY; Zheng Y; Ren PR; Lin S; Wen QL; He LJ; Zhang JW; Shang CL; Yang HR; Fan J; Pang HW; Zhang J; Tan BX; Zhang L; Du XB; Wen SM; Jiang L; Qin G; Wu JB
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):914-924. PubMed ID: 37356553
[TBL] [Abstract][Full Text] [Related]
4. Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study.
Miao J; Wang L; Ong EHW; Hu C; Lin S; Chen X; Chen Y; Zhong Y; Jin F; Lin Q; Lin S; Hu X; Zhang N; Wang R; Wang C; Guo X; Yit NLF; Shi H; Tan SH; Mai H; Xie C; Chua MLK; Zhao C
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):815-825. PubMed ID: 36872457
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study.
Liu L; Fei Z; Chen M; Zhao L; Su H; Gu D; Lin B; Cai X; Lu L; Gao M; Ye X; Jin X; Xie C
Radiat Oncol; 2018 Aug; 13(1):148. PubMed ID: 30103765
[TBL] [Abstract][Full Text] [Related]
6. Can Epstein-Barr virus-deoxyribonucleic acid load after induction chemotherapy combined with American Joint Committee on Cancer stage determine the chemotherapy intensity of locally advanced nasopharyngeal carcinoma?
Zhang Q; Peng ZW; Gu ZS; Wang Y; He F; Zhao WB; Luo W; Mei YY
Cancer Med; 2023 Jan; 12(1):223-235. PubMed ID: 35674137
[TBL] [Abstract][Full Text] [Related]
7. Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy.
Zhao DW; Fang XM; Zhou SH; Luo YR; Wei J; Liu K; Meng LL; Liu G; Li JF; Zang X; Li M; Qiang XF; Jiang HY; Fan WJ; Zhang XX; Ma L
Front Oncol; 2022; 12():870315. PubMed ID: 35664750
[TBL] [Abstract][Full Text] [Related]
8. Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study.
Zhao C; Miao JJ; Hua YJ; Wang L; Han F; Lu LX; Xiao WW; Wu HJ; Zhu MY; Huang SM; Lin CG; Deng XW; Xie CH
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):836-844. PubMed ID: 30954521
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma.
Wang M; Xi Y; Wang L; Chen H; Jiang F; Ding Z
Radiat Oncol; 2024 Feb; 19(1):26. PubMed ID: 38418994
[TBL] [Abstract][Full Text] [Related]
10. Clinical observation of submandibular gland transfer for the prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma: a prospective randomized controlled study of 32 cases.
Zhang X; Liu F; Lan X; Yu L; Wu W; Wu X; Xiao F; Li S
Radiat Oncol; 2014 Feb; 9():62. PubMed ID: 24555575
[TBL] [Abstract][Full Text] [Related]
11. Determination of optimum number of cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a single-center retrospective study.
Ahmed AO; Wang J; Wu Q; Zhong Y
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1999-2006. PubMed ID: 36629931
[TBL] [Abstract][Full Text] [Related]
12. Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
Fan WJ; Teng F; Liu G; Zhao DW; Li JF; Luo YR; Zhang XX; Ma L; Guan J
Radiother Oncol; 2021 Apr; 157():247-254. PubMed ID: 33587972
[TBL] [Abstract][Full Text] [Related]
13. [Long-term efficacy of submandibular gland transfer for prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma].
Zhang X; Yu L; Wu W; Wu X; Xiao F; Zeng G; Lan X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 27(3):128-30, 133. PubMed ID: 23700804
[TBL] [Abstract][Full Text] [Related]
14. Cognitive dysfunction in patients with nasopharyngeal carcinoma after induction chemotherapy.
Wang J; Lian CL; Zheng H; Lin LE; Yu YF; Lin Q; Wu SG
Oral Oncol; 2020 Dec; 111():104921. PubMed ID: 32763779
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients.
Zhao DW; Teng F; Meng LL; Fan WJ; Luo YR; Jiang HY; Chen NX; Zhang XX; Yu W; Cai BN; Zhao LJ; Wang PG; Ma L
Radiother Oncol; 2023 Jul; 184():109683. PubMed ID: 37120102
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy in nasopharyngeal carcinoma- A systematic review of phase III clinical trials.
Nazeer F; Poulose JV; Kainickal CT
Cancer Treat Res Commun; 2022; 32():100589. PubMed ID: 35724627
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers.
Tao HY; He F; Shi QY; Liu R; Wang ZL; Du KP; Li JF; Liu H; Lu ZQ; Zhang JJ; Bai YH
Cancer Med; 2023 Mar; 12(6):6811-6824. PubMed ID: 36420689
[TBL] [Abstract][Full Text] [Related]
19. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
[TBL] [Abstract][Full Text] [Related]
20. Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.
Liu SL; Sun XS; Yan JJ; Chen QY; Lin HX; Wen YF; Guo SS; Liu LT; Xie HJ; Tang QN; Liang YJ; Li XY; Lin C; Du YY; Yang ZC; Xiao BB; Yang JH; Tang LQ; Guo L; Mai HQ
Radiother Oncol; 2019 Aug; 137():83-94. PubMed ID: 31078941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
